Burundi vs India: Cause of death, by non-communicable diseases, ages 5-14, female
Burundi
19.3%
in 2021
India
19.8%
in 2021
Burundi rank
160th
India rank
157th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Burundi
- India
How they compare
India currently reports 19.8% against 19.3% in Burundi, a difference of 0.5%.
Across all 6 years both countries report, India has been ahead every year.
Burundi ranks 160th and India ranks 157th of 184 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.4% | 14.6% | 2.2% | India |
| 2010s | 16.6% | 18.4% | 1.8% | India |
| 2020s | 18.9% | 20.4% | 1.5% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Burundi or India?
- India, at 19.8% against 19.3% in Burundi as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Burundi and India?
- 0.5%, with India ahead.
- How many years of comparable data are there for Burundi and India?
- 6 years are reported by both, from 2000 to 2021.
- How do Burundi and India rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Burundi ranks 160th and India ranks 157th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.